The third stage of labor is the short but critical window between the birth of your baby and the delivery of the placenta. It typically lasts between five and fifteen minutes, though it can stretch to thirty or more. What happens during those minutes, and how your care team manages them, directly affects your risk of heavy bleeding afterward. Despite being the least talked-about phase of childbirth, the third stage is the focus of intense clinical attention, because postpartum hemorrhage remains a leading cause of maternal death worldwide.
What Actually Happens During the Third Stage
Once the baby is born, the uterus continues to contract. These contractions serve a different purpose now: they shear the placenta away from the uterine wall. The placenta is attached to the inner lining of the uterus through a dense network of blood vessels. As the uterus shrinks and the muscle fibers tighten, the attachment site gets smaller while the placenta itself stays the same size, which buckles the connection and peels the placenta free. After separation, a few more contractions push the placenta down through the cervix and out through the vagina. The same contracting muscle fibers then clamp down on the exposed blood vessels at the former attachment site, acting as a living tourniquet. This is why the uterus contracting well after delivery is so important: a soft, relaxed uterus cannot pinch off those vessels, and heavy bleeding follows.
Active Management Versus Waiting
Care teams have two broad approaches to the third stage. Active management traditionally involves giving a drug to strengthen uterine contractions (a uterotonic), applying gentle downward traction on the umbilical cord to guide the placenta out, and sometimes massaging the top of the uterus. Expectant, or physiological, management means letting the placenta deliver on its own, intervening only if something goes wrong.
A large Cochrane review found that active management reduces average blood loss at birth and likely cuts the rate of significant bleeding compared with expectant management.1PubMed Central. Active versus expectant management for women in the third stage of labour The Bristol third stage trial, one of the landmark studies, put numbers on the difference: postpartum hemorrhage occurred in about 6% of women managed actively versus roughly 18% managed physiologically, and the median duration of the third stage was five minutes versus fifteen.2British Medical Journal. The Bristol third stage trial: active versus physiological management of third stage of labour
The picture is not perfectly tidy, though. One randomized trial found that while active management shortened the third stage, it did not significantly reduce blood loss during it, and blood loss in the hour after placental delivery was actually higher in the actively managed group.3PubMed. Comparison of active and expectant management on the duration of the third stage of labour and the amount of blood loss during the third and fourth stages of labour: a randomised controlled trial This kind of nuance has pushed researchers to look at each component of active management separately rather than treating the whole bundle as one intervention.
Why the Term “Active Management” Is Falling Out of Favor
For years, active management of the third stage was taught as a package deal. More recently, experts have argued that lumping several interventions together under one label creates confusion, because the evidence behind each component is not equally strong. A 2024 review in the American Journal of Obstetrics and Gynecology recommended dropping the term altogether in favor of “third stage care,” which encourages clinicians to evaluate each practice individually and adopt only those with clear evidence of benefit for both the mother and the newborn.4PubMed. Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes Early cord clamping, for example, was once part of the standard active management bundle, but evidence showing that it shortchanges the baby’s blood volume led most guidelines to reverse course. The shift toward component-by-component thinking is one of the bigger changes in obstetric practice in recent decades.
Uterotonics Are the Most Important Single Intervention
Of all the tools used during the third stage, the uterotonic drug is the one that matters most for preventing heavy bleeding. Oxytocin, given by injection shortly after birth, is the most widely used option. A Cochrane review found that prophylactic oxytocin roughly halved the risk of losing 500 mL or more of blood after delivery and cut the risk of severe hemorrhage (1,000 mL or more) by about 40%, compared with giving no uterotonic at all.5PubMed Central. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage It also reduced the need for additional bleeding medications afterward.
How the oxytocin is given turns out to matter, too. A meta-analysis comparing intramuscular injection to intravenous delivery found that the intramuscular route was associated with higher rates of severe hemorrhage, more blood transfusions, and more cases requiring manual removal of the placenta.6PubMed. A meta-analysis of the effects of intramuscular and intravenous injection of oxytocin on the third stage of labor A three-arm randomized trial confirmed that blood loss was lower with intravenous bolus or infusion compared with intramuscular injection, and the risk of losing 500 mL or more was about half as high with intravenous infusion.7PubMed Central. Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial In many settings, though, intramuscular injection remains the default because it does not require an intravenous line and is simpler to administer.
A large WHO-supported trial showed that the uterotonic is the core component of third-stage management. When researchers compared the full package of active management (uterotonic plus controlled cord traction) against a simplified version (uterotonic alone), the difference in severe hemorrhage was tiny: roughly one additional case for every 581 women who received only the uterotonic.8The Lancet. Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial The conclusion was clear: if resources or skills are limited, the priority should be the uterotonic.
Controlled Cord Traction on Its Own
Controlled cord traction means applying gentle, steady downward pressure on the cord while the other hand stabilizes the uterus through the abdomen, to guide the separated placenta out. A Cochrane review of trials involving over 27,000 women found that cord traction did not reduce the risk of severe hemorrhage but did lower the chance of needing the placenta removed by hand by about 30%.9PubMed Central. Controlled cord traction for the third stage of labour It also shortened the third stage and produced a modest reduction in moderate blood loss. For trained providers, it is a low-risk addition. For births attended by people without that training, the evidence suggests it is safe to skip and rely on the uterotonic alone.
When to Clamp the Cord
Cord clamping used to happen almost immediately after birth. That has changed. Current guidelines from the World Health Organization and most national obstetric bodies recommend waiting at least one to three minutes. The reason is straightforward: blood continues to flow from the placenta into the baby for several minutes after delivery. Clamping early cuts that transfer short, depriving the newborn of extra red blood cells and iron.
Research consistently shows that delayed clamping leads to higher hemoglobin levels and better iron stores in the baby, less anemia, and in preterm infants, lower rates of brain bleeds and other serious complications.10PubMed Central. Early versus delayed umbilical cord clamping on maternal and neonatal outcomes A Jordanian study also found that early clamping was associated with a higher need for oxygen therapy in the newborn and more postpartum hemorrhage in the mother.11PubMed. Effects of early umbilical cord clamping versus delayed clamping on maternal and neonatal outcomes: a Jordanian study A study of over 900 mother-infant pairs found no negative consequences of waiting beyond three minutes, with benefits including improved oxygen levels in the newborn immediately after birth.12PubMed Central. Cord clamping beyond 3 minutes: Neonatal short‐term outcomes and maternal postpartum hemorrhage That study also found no increase in the risk of jaundice requiring treatment, a concern that has historically been used to argue against delaying.
Skin-to-Skin Contact and Your Body’s Own Oxytocin
Placing the baby directly on the mother’s bare chest right after birth does more than promote bonding. It triggers a hormonal cascade that helps the third stage along. When the baby touches the mother’s skin, the posterior pituitary gland releases oxytocin into the bloodstream. When the baby begins to nuzzle or suckle at the breast, that oxytocin surge intensifies. The same hormone that was driving labor contractions now drives the uterine contractions that separate and expel the placenta.13PubMed Central. The Effect of Mother-Infant Skin to Skin Contact after Birth on Third Stage of Labor: A Systematic Review and Meta-Analysis Even the baby’s kicking and foot movements on the mother’s abdomen act as a kind of natural uterine massage.
A trial comparing skin-to-skin contact during the third stage with standard care found that the placenta separated in an average of about seven minutes in the skin-to-skin group versus about thirteen minutes in the control group, a statistically significant difference.14PubMed. The Effect of Skin-to-Skin Contact on Placental Separation Time and Initiation of Breastfeeding This is a genuinely free, zero-risk intervention. It works alongside any medications being given and also supports breastfeeding initiation.
Retained Placenta
Sometimes the placenta does not come out on its own. A retained placenta is usually diagnosed when it has not delivered within about 18 to 60 minutes (definitions vary by guideline) or when heavy bleeding starts before the placenta appears. Risk factors include a history of uterine surgery, preterm birth, high parity, prolonged oxytocin use during labor, and pregnancies conceived through assisted reproductive technology.15PubMed Central. Retained placenta after vaginal delivery: risk factors and management A multicenter study found that assisted reproductive technology was the strongest independent risk factor for needing manual removal, raising the odds more than eightfold.16PubMed. Manual removal of the placenta and postpartum hemorrhage: A multicenter retrospective study
Manual removal means the provider reaches into the uterus and peels the placenta away by hand, usually under regional or general anesthesia. It is safe when performed by a skilled provider, but it carries a higher risk of infection and blood loss than a spontaneous delivery. In rare cases, a retained placenta signals a deeper problem: the placenta has grown into the uterine muscle, a condition known as placenta accreta spectrum. These cases sometimes only become apparent when the placenta fails to detach during the third stage of a vaginal delivery.17ScienceDirect (American Journal of Obstetrics & Gynecology MFM). Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity
Uterine Inversion, a Rare Emergency
Uterine inversion, where the uterus turns partially or completely inside out during the third stage, is uncommon but dangerous. It can happen when the placenta is implanted at the top of the uterus and the combination of cord traction and fundal pressure causes the uterine wall to fold inward. A case report described complete inversion occurring after an otherwise normal delivery with no cord traction, where the sole identified risk factor was the placenta being attached to the top of the uterus.18PubMed Central. Total and acute uterine inversion after delivery: a case report Prompt diagnosis and immediate manual replacement of the uterus are crucial. If initial manual attempts fail, drugs that relax the uterine muscle or surgical correction may be needed.19Obstetrics and Gynecology Clinics of North America. EMERGENT OBSTETRIC MANAGEMENT OF UTERINE INVERSION With rapid treatment, outcomes are generally good.
How Blood Loss Is Measured (and Why It Matters)
One of the persistent problems in third-stage care is figuring out how much blood has actually been lost. For decades, providers have relied on visual estimation, essentially looking at the blood-soaked pads and drapes and guessing. This method is wildly inaccurate. FIGO (the International Federation of Gynecology and Obstetrics) has stated that visual estimation often leads to underdiagnosis and delayed response to hemorrhage, and recommends objective measurement instead.20PubMed Central. FIGO recommendations on objective measurement of blood loss after birth for early detection of postpartum hemorrhage
A study comparing automated blood-loss measurement to visual estimation in nearly 275 vaginal deliveries showed just how far off eyeballing can be. Quantitative measurement identified blood loss of 500 mL or more in about 27% of patients, while visual estimation flagged only 5%. At the severe end, quantitative methods caught eleven cases of 1,000 mL or more; visual estimation caught one.21PubMed. Automated Quantification of Blood Loss versus Visual Estimation in 274 Vaginal Deliveries Speed matters when postpartum hemorrhage develops: delays in giving oxytocin, examining the uterus, or calling for help have each been independently associated with the bleeding becoming more severe.22PubMed Central. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity Accurate measurement triggers earlier action, which is why many hospitals are moving toward weighing blood-soaked materials or using calibrated collection drapes.
The Cold-Chain Problem and Heat-Stable Carbetocin
Oxytocin needs to be kept refrigerated. In many low-income settings, reliable cold storage is not available, and heat-degraded oxytocin works poorly. This cold-chain requirement is one reason postpartum hemorrhage kills so many women in parts of sub-Saharan Africa and South Asia. Heat-stable carbetocin, a synthetic oxytocin analogue that does not require refrigeration, was developed to address this gap. A comprehensive review found that it offers a viable, cost-effective alternative in low- and middle-income settings where cold-chain infrastructure is unreliable.23PubMed Central. Heat-Stable Carbetocin in the Management of Postpartum Haemorrhage in Low- and Middle-Income Countries: A Comprehensive Review of Clinical Evidence, Cost-Effectiveness, Implementation Challenges and Adoption Strategies
A cost-effectiveness study modeled the impact of heat-stable carbetocin in Uganda and estimated it could prevent over 57,000 cases of postpartum hemorrhage and avert more than 120 maternal deaths annually compared with oxytocin, while actually saving the healthcare system money. Compared with misoprostol (another heat-stable option, but less effective), the benefits were even larger: nearly 74,000 fewer hemorrhage cases and over 270 fewer deaths.24PubMed Central. Cost-effectiveness results comparing heat-stable carbetocin & other uterotonics in postpartum heamorrhage prevention in Uganda For regions where a reliable power grid is not a given, heat-stable carbetocin is arguably the single highest-impact advance in third-stage care in years.
Cord Blood Banking and Delayed Clamping
Parents who plan to donate or bank cord blood sometimes wonder whether delayed cord clamping will leave too little blood in the cord for collection. This tension is real but manageable. A study tracking cord blood units found that while the volume of blood collected dropped as the clamping delay increased, the total number of nucleated cells (the cells that matter for transplantation) held steady for delays up to about two minutes.25PubMed Central. Efficiency assessment of cord blood banking and compatibility with delayed cord clamping A clamping delay of 30 to 60 seconds appears fully compatible with collecting a usable unit for public cord blood banking.
Beyond 60 seconds, collection quality drops more sharply. One study found that the rate of clinically useful cord blood units fell tenfold when clamping was delayed past one minute, and nearly half of those units had volumes too small to use.26PubMed. Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors? So there is a practical compromise: a delay of about 30 to 60 seconds gives the baby a meaningful blood transfer and still allows a viable cord blood donation. For families who want the full three-minute delay recommended for the baby’s benefit, cord blood banking will likely not yield a transplant-quality unit, and the baby’s health generally takes priority in that conversation.
Placental Inspection and Emerging Technology
After the placenta is delivered, the provider examines it. The goal is to make sure it came out in one piece. A missing fragment left behind in the uterus can cause ongoing bleeding or infection. The standard approach is a careful visual and manual inspection of the maternal surface and membranes. Researchers have begun exploring whether artificial intelligence could improve this process. One project developed a system that uses photographs of the delivered placenta to detect retained tissue, umbilical cord knots, and signs of conditions like placental abruption or infection.27PubMed Central. AI-PLAX: AI-based placental assessment and examination using photos This kind of tool could be especially useful in settings where experienced providers are scarce. Placental inspection is also an underappreciated source of clinical information: features like the cord insertion point, the color of the membranes, and the presence of clots or calcifications can offer clues about what happened during the pregnancy, even though these findings rarely change immediate postpartum management.
Why Most Mammals Eat the Placenta and Humans Do Not
Nearly all non-human mammals consume the placenta immediately after delivery. This behavior appears to have several functions, including triggering opioid circuits in the brain that support maternal bonding and pain relief, and suppressing hormonal states that would interfere with lactation.28PubMed. Placentophagia in humans and nonhuman mammals: causes and consequences Humans are a striking exception. The practice of placentophagy has seen a pop-culture resurgence, with capsules made from dehydrated placenta marketed for mood support and milk production, but no rigorous evidence supports those claims. Researchers have framed the more interesting question as why humans stopped rather than why some have started again. One hypothesis is that human social structures, food supply, and extended infant dependency reduced the selective pressure for the behavior. Whatever the reason, the placenta in clinical practice is treated as medical waste, inspected for completeness, and discarded.